Regulatory News In Brief
This article was originally published in The Gray Sheet
FDA town hall meeting
You may also be interested in...
CDRH town halls – 2011 edition
White House scrutinizes human research
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.